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Abstract In the present study, fluorescent in situ hybrid-
ization (FISH) and monoclonal antibodies (MAbs) were
evaluated for species-specific detection and viability
determination of Giardia lamblia, Cryptosporidium par-
vum, and Cryptosporidium hominis in human fecal and
water supply samples. A total of 50 fecal human samples
positive for G. lamblia cysts, 38 positive for C. parvum,
and 23 positive for C. hominis were studied. Also, 18 water
supply samples positive for Giardia spp. and Cryptospo-
ridium spp. by the United States Environmental Protection
Agency (USEPA) Method 1623 were studied by FISH and
fluorescein isothiocyanate (FITC)-conjugated MAbs. Eigh-
teen percent of the fecal samples parasitologically positive
for G. lamblia presented viable and nonviable cysts, and
5% of those positive for Cryptosporidium spp. presented
viable and nonviable oocysts. Of the 18 water supply
samples analyzed, 6 (33%) presented Giardia spp. viable
and nonviable cysts and 2 (11%) presented viable and
nonviable Cryptosporidium spp. oocysts. G. lamblia
identification was confirmed by polymerase chain reaction
(PCR) and sequencing of the β-giardin gene in the fecal
and water samples found positive by FISH and FITC-con-
jugated MAbs. C. parvum and Cryptosporidium muris
were identified, by PCR and sequencing of the small sub-
unit of ribosomal RNA gene, in seven and one water sam-
ples, respectively. Our results confirm that this technique
enables simultaneous visualization, species-specific iden-
tification, and viability determination of the organisms
present in human fecal and water supply samples.
Keywords Giardia lamblia . Cryptosporidium parvum .
Cryptosporidium hominis . Detection . Viability . Water
supply samples . FISH . MAbs
Introduction
Cryptosporidium spp. and Giardia spp. are pathogenic
protozoan parasites with a worldwide distribution that
cause diarrheal illness in humans and animals (Matos et al.
1998; Slifko et al. 2000). Waterborne transmission prob-
ably plays a major role in the spread of both infections to
large amounts of population. Several outbreaks of crypto-
sporidiosis and giardiosis, with different magnitudes attrib-
uted to water supplies contaminated with (oo)cysts, have
been reported (Mac Kenzie et al. 1994; Slifko et al. 2000).
Potential sources of (oo)cysts in water supplies include
wastewater of human origin and feces from many mam-
malian species, including cattle and beaver (Solo-Gabriele
et al. 1998; Ono et al. 2001). Both cysts and oocysts are
capable of surviving environmental stresses, and filtration,
flocculation, sedimentation, and disinfection, commonly used
for water purification, are not completely effective in re-
moving or inactivating them (Tzipori and Ward 2002).
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The immunofluorescent assay currently used does not
distinguish between viable and nonviable (oo)cysts. Direct
microscopic examination of the internal structure of these
infective stages and methods based on the uptake of vital
dyes are labor intensive and are not applied for routine
analysis.
Since only viable (oo)cysts are of significant interest for
public health, it is of great interest for the water industry to
have a reliable test for characterization of the viability of
waterborne (oo)cysts that detect infections. Recently, the
fluorescent in situ hybridization (FISH) technique utilizing
fluorescent-labeled complimentary DNA oligonucleotide
probes targeted to specific sequences of cell ribosomal
RNA (rRNA) has been described (Amann et al. 1995).
rRNA provides a unique target for nucleic acid probes,
as rRNA target molecules are generally present in high
numbers in viable cells and degree of specificity (genus,
species, etc.) may be designed (Vesey et al. 1998; Moter
and Gobel 2000; Smith et al. 2004). Graczyk et al. 2003,
tested the suitability and optimized a protocol for dual
labeling, FISH and fluorescein isothiocyanate (FITC)-con-
jugated monoclonal antibody (MAb) for the specific
detection and viability determination of Giardia lamblia,
Cryptosporidium parvum, and Cryptosporidium hominis
carried by synanthropic flies. Incorporation of FITC-con-
jugated MAb into the FISH protocol allows observation of
the external morphology of pathogens and assessment of
any structural damage to their walls that can lead to
nonviability.
The aim of this study was to determine the applicability
of FISH with MAbs to the detection and viability deter-
mination of three protozoa species, G. lamblia, C. parvum,
and C. hominis, isolated from human fecal and water sup-
ply samples. Hybridization protocols were optimized for
getting a better concentration of oligonucleotide probe ap-
plied and the volume of samples used.
Materials and methods
Identification and processing of G. lamblia cysts and C.
parvum and C. hominis oocysts Fecal samples from pa-
tients with diarrhea, obtained between 1997 and August
2004, were analyzed retrospectively: 50 with G. lamblia
cysts, detected on fecal smears after concentration, fol-
lowed by Lugol staining and 61 with Cryptosporidium
spp. oocysts detected by modified Ziehl–Neelsen staining.
These Cryptosporidium spp. isolates had been pre-
viously genotyped by polymerase chain reaction–restric-
tion fragment length polymorphism (PCR–RFLP) at the
small subunit (SSU)-rRNA locus (Alves et al. 2001): 38
were identified as C. parvum and 23 as C. hominis. There
were samples with low, moderate, and high parasite load.
Samples positive for G. lamblia, C. parvum, and C. hominis
were stored at 4°C in an equal volume of 5% potassium
dichromate solution for several years.
Eighteen water supply samples recovered from the en-
vironment by the United States Environmental Protection
Agency (USEPA) Method 1623 (USEPA 1998), between
2003 and 2005, and kept at 4°C, were analyzed retrospec-
tively: all samples were positive for Giardia spp. and
Cryptosporidium spp. USEPA Method 1623 requires the
concentration of water samples by filtration, immunomag-
netic separation of the (oo)cysts from concentrated debris,
detection of (oo)cysts by immunofluorescent assay, and
viability determination by 4′-6-diamidino-2-phenylindole
(DAPI).
Identification of Cryptosporidium spp. present in water
supply Oocysts recovered from water samples after the
immunomagnetic separation were submitted to DNA ex-
traction by a MiniBeadBeaters/Silica method. Then, the
species identification of these parasites was performed
by PCR and by sequencing of the SSU-rRNA amplicon
(Alves et al. 2001).
Oligonucleotide probes Three oligonucleotide probes,
species-specific complementary to the 18S rRNA region,
were used for the FISH technique. Two probes specific for
G. lamblia were used: Giar-4 (5′-CGGCGGGGGGCCAAC
TAC-3′) and Giar-6 (5′-CGGGGCTGCCGCGGCGCG-3′;
Dorsch andVeal 2001). AC. parvum- andC. hominis-specific
oligonucleotide probe, CRY-1 (5′-CGGTTATCCATGTAAG
TAAAG-3′), was used (Vesey et al. 1998). The Giar-4, Giar-6,
and CRY-1 oligonucleotide probes were synthesized by
Thermo Electron GmbH in a 0.2-μM scale, purified using
reverse-phase high-performance liquid chromatography,
and labeled with a single molecule of fluorochrome hexa-
chlorinated 6-carboxyfluorescein (HEX) to the 5′ end.
MAbs An FITC-conjugated combination of MAbs specific
to the cell wall antigens of Giardia spp. and Cryptospo-
ridium spp. from the MerifluorTM Cryptosporidium/
Giardia test kit (Meridian Bioscience, Inc., 3471 River
Hills, Cincinnati, OH, USA) was used.
FISH and FITC-conjugated MAbs in human fecal and
water supply samples Fluorescent in situ hybridization and
FITC-conjugated MAbs method was carried out as de-
scribed previously (Graczyk et al. 2003). Hybridization
protocols were optimized to get better results in fecal and
water samples. Hence, the final concentration of each oli-
gonucleotide probe used in human fecal and water supply
samples was 2 and 10 pmol/μl, respectively. Also, the
final volume of fecal and water samples analyzed was 500
and 100 μl, respectively.
Epifluorescence microscopy The wells were covered and
examined with an Olympus epifluorescence microscope
with ×40 and ×100 oil immersion objective lenses, and a
BP-490 exciter filter was used.
Species confirmation of Giardia spp. parasites by molec-
ular methods All FISH and FITC-conjugated MAbs fecal
and water samples positive for Giardia spp. cysts were
submitted to genomic DNA extraction. Cysts were con-
centrated from whole feces by a modified water–ether
sedimentation method, and genomic DNA was isolated
49
from concentrated cysts by a MiniBeadBeaters/Silica meth-
od (Alves et al. 2001). The water samples were submitted
to the same DNA extraction method after the immunomag-
netic separation.
The β-giardin gene locus was PCR-amplified as pre-
viously described (Caccio et al. 2002) to characterize
Giardia spp. cysts at the molecular level, followed by
sequencing.
Results
Labeling of fecal and water samples based on FISH and
FITC-conjugated MAbs One hundred eleven fecal samples
from patients with diarrhea, obtained between 1997 and
August 2004, were analyzed retrospectively: of the 50
samples positive parasitologically for G. lamblia, 9 (18%)
had viable cysts detected by FISH with MAb. Of the 61
fecal samples with C. parvum and C. hominis, 3 (5%) had
viable oocysts detected by FISH and FITC-conjugated MAb
(Table 1). Eighteen water supply samples were analyzed
by FISH with MAb, 2 weeks to 5 months after collection
and processing according to USEPA Method 1623. Six
(33%) of the 18 samples studied presented viable and non-
viable Giardia spp. cysts, and 2 (11%) out of the 18 sam-
ples had viable and nonviable Cryptosporidium spp.
oocysts detected (Table 1).
Potentially viable (oo)cysts were clearly differentiated
from nonviable ones by color. Viable (oo)cysts were re-
presented by intact green shells and were filled out com-
pletely with red cytoplasm, and the viable (oo)cysts were
red inside as a result of FISH and had a green shell as a
Table 1 Results of FISH and
FITC-conjugated MAbs
method on the identification
and determination of the
viability of (oo)cysts in the
fecal and water supply samples
parasitologically positive
for Giardia spp. and Crypto-
sporidium spp. and confirmation
of specificity of the probes
used by molecular methods

















Positive samples (%) Negative
samples (%)
Feces Giardia spp. 50 9 (18) 41 (82) G. lamblia (3)
Cryptosporidium
spp.
61 3 (5) 58 (95) C. parvum (2)
C. hominis (1)
Water Giardia spp. 18 6 (33) 12 (67) G.lamblia (1)
Cryptosporidium
spp.




Fig. 1 Distribution of the viable
G. lamblia cysts in fecal sam-
ples between 2000 and 2004
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result of MAbs, as described previously (Graczyk et al.
2003).
With FISH and FITC-conjugated MAbs, viable (oo)
cysts were detected in fecal samples with high, moderate,
and low parasite loads. Viable Giardia spp. cysts were
detected in fecal samples collected from 2000 until 2003
(Fig. 1), and viable Cryptosporidium spp. oocysts in fecal
samples were recovered in 2000, 2003, and 2004 (Fig. 2).
The highest percentage of viable (oo)cysts in feces was
detected in 2003 (Figs. 1 and 2).
In the water supply samples studied, viable cysts (Fig. 3)
were detected in 2003, 2004, and 2005, and viable oocysts
were identified only in 2005.
Identification of Cryptosporidium spp. present in water
supply All 18 water samples analyzed by FISH and FITC-
conjugated MAbs, independent of being positive or neg-
ative, were submitted to PCR and sequencing at the
SSU-rRNA locus. Isolates in 10 of the 18 water samples
found positive by USEPA Method 1623 were successfully
Fig. 2 Distribution of the viable
Cryptosporidium spp. oocysts
in fecal samples between 1997
and 2004
Fig. 3 Distribution of the viable
Giardia spp. cysts and Crypto-
sporidium spp. oocysts in water
supply samples between 2003
and 2005
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identified to the species level. C. parvum was implicated in
the contamination of seven samples and Cryptosporidium
muris in one. In two samples, the quality of the sequencing
was poor and the sequence obtained could not differentiate
between C. parvum and C. hominis. None of these samples
was found positive by FISH and FITC-conjugated MAbs.
The oligonucleotide probe used to detect C. parvum and C.
hominis did not detect C. muris.
Species confirmation of Giardia spp. parasites by molec-
ular methods Confirmation of Giardia spp. in fecal and
water samples found positive by FISH and FITC-con-
jugated MAbs was achieved by PCR amplification of the
β-giardin gene locus, followed by sequencing. This locus
was successfully amplified in five fecal and four water sam-
ples. The sequence analysis was successfully obtained on
the amplicons of the isolates of three fecal samples and of
one water sample revealing 100% identity with G. lamblia
Portland-1 (GenBank accession numbers: XO7919, X85958,
X14185, and M36728).
Discussion
In the present study, the main objective was to determine if
FISH and FITC-conjugated MAbs could have a role in the
specific detection and viability determination of environ-
mental parasites, voided in feces of animals or humans,
more specifically G. lamblia, C. parvum, and C. hominis in
water supply samples. This method was primarily applied
to human fecal samples stored at 4°C for several years and
lately applied to water supply samples stored for 2 weeks
to 5 months. With FISH and FITC-conjugated MAbs, 9
(18%) out of 50 human feces parasitologically positive for
G. lamblia and 3 (5%) out of 61 feces parasitologically
positive for C. parvum and C. hominis presented viable and
nonviable cysts and oocysts, respectively. A greater amount
of nonviable (oo)cysts were detected in the oldest fecal
samples, corroborating the results obtained in other studies
(Jenkins et al. 2003; Surl et al. 2003). Viable Giardia spp.
cysts and Cryptosporidium spp. oocysts were obtained
since 2000, corroborating also the idea that both protozoa
can remain infectious over the years since they are very
resistant in adverse environmental conditions.
After the successful application of this method in fecal
samples, it was used to analyze 18 water supply samples
positive for Giardia spp. and Cryptosporidium spp. by
USEPA Method 1623. Viable and nonviable cysts of G.
lamblia were identified in six (33%) water samples, and
oocysts of C. parvum and C. hominis were detected in two
(11%) water samples.
In general, more viable protozoa were found in feces
than in water supply samples, which may be due to the
higher parasite load, ease in detection, presence in feces
than in water, and/or the small volume of water supply
samples analyzed in this study. Also, G. lamblia cysts were
detected in older samples (fecal and water samples), as
against Cryptosporidium spp. oocysts. Viable Cryptospo-
ridium spp. oocysts were detected only in the water
samples analyzed by FISH and FITC-conjugated MAbs,
the maximum of which was 2 weeks after recovery from
the environment. Oocysts are probably more sensitive to
manipulation by USEPA Method 1623 than cysts. Water
samples must be submitted to FISH and FITC-conjugated
MAbs for Giardia spp. and Cryptosporidium spp. imme-
diately after recovery by the USEPA methods to overcome
this problem, and a larger amount of water sample should
be analyzed by this method.
In samples with Giardia spp., the molecular methods
used to confirm the specificity of FISH and FITC-conju-
gated MAbs showed that the oligonucleotide probes used
to detect G. lamblia are specific for this species. The oligo-
nucleotide probe used to detect C. parvum and C. hominis
also showed to be specific for these two species, as it did
not detect C. muris in one water sample with this species.
Nevertheless, it can also be due to loss of integrity of the
oocysts since this was one of the samples studied by FISH
and FITC-conjugated MAbs 1 month after its recovery
from the environment and storage at 4°C.
Contaminated water with G. lamblia, C. parvum, and C.
hominis is an important source of human infection, either
by direct consumption or by the use of contaminated water
in food processing or preparation. Water transports trans-
missible stages into drinking water supplies, which, in turn,
can contaminate the food supply through agricultural and
food industry practices. In Portugal, although G. lamblia
and Cryptosporidium spp. are recognized as common par-
asites in humans, little information on the prevalence and
identity of these parasites’ isolates from water is available.
With FISH and FITC-conjugated MAbs, the percentage
of Cryptosporidium spp. oocysts found in water samples
contaminated with oocysts of this parasite was low, sug-
gesting that the practical application of FISH assay in water
samples will require the development of methods capable
of concentrating particulates from large volumes of water
without affecting protozoa integrity.
FISH and FITC-conjugated MAbs provide information
about the presence, the number, as well as the morphology
and viability of the microorganism species involved in the
contamination.
In conclusion, this study corroborates other opinions
(Vesey et al. 1998; Graczyk et al. 2003; Smith et al. 2004)
showing that FISH and FITC-conjugated MAbs is a highly
specific and a sensitive assay for the detection of viable
protozoa in fecal and environmental samples. Being a fast
and cheap method, it combines the precision of molecular
genetics with the visualization and identification of proto-
zoa in comparison with parasitological methods, used for
diagnosis and morphological studies, combined with PCR–
RFLP or DNA sequencing for species determination and
with reverse transcriptase PCR for the evaluation of via-
bility of microorganisms. Besides, this study sets the frame-
work for further work on the presence of G. lamblia and
Cryptosporidium spp. contamination in water and its im-
portance in the field of public health in Portugal.
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